Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Assets:
Cash and cash equivalents	$ 7,854.0	$ 5,683.0
Investments	3,000.0	2,373.0
Accounts receivable, net	21,742.0	19,617.0
Inventories	18,496.0	17,516.0
Other current assets	5,277.0	5,113.0
Total current assets	56,369.0	50,302.0
Long-term investments	20,812.0	17,314.0
Property and equipment, net	12,606.0	12,044.0
Operating lease right-of-use assets	20,729.0	20,860.0
Goodwill	79,552.0	79,749.0
Intangible assets, net	31,142.0	33,121.0
Separate accounts assets	4,881.0	4,459.0
Other assets	4,624.0	4,600.0
Total assets	230,715.0	222,449.0
Liabilities:
Accounts payable	11,138.0	10,492.0
Pharmacy claims and discounts payable	15,795.0	13,601.0
Health care costs payable	7,936.0	6,879.0
Policyholders’ funds	4,270.0	2,991.0
Accrued expenses	14,243.0	12,133.0
Other insurance liabilities	1,557.0	1,830.0
Current portion of operating lease liabilities	1,638.0	1,596.0
Current portion of long-term debt	5,440.0	3,781.0
Total current liabilities	62,017.0	53,303.0
Long-term operating lease liabilities	18,757.0	18,926.0
Long-term debt	59,207.0	64,699.0
Deferred income taxes	6,794.0	7,294.0
Separate accounts liabilities	4,881.0	4,459.0
Other long-term insurance liabilities	7,007.0	7,436.0
Other long-term liabilities	2,351.0	2,162.0
Total liabilities	161,014.0	158,279.0
Commitments and contingencies (Note 16)
Shareholders’ equity:
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	0.0	0.0
Common stock, par value $0.01: 3,200 shares authorized; 1,733 shares issued and 1,310 shares outstanding at December 31, 2020 and 1,727 shares issued and 1,302 shares outstanding at December 31, 2019 and capital surplus	46,513.0	45,972.0
Treasury stock, at cost: 423 and 425 shares at December 31, 2020 and 2019	(28,178.0)	(28,235.0)
Retained earnings	49,640.0	45,108.0
Accumulated other comprehensive income	1,414.0	1,019.0
Total CVS Health shareholders’ equity	69,389.0	63,864.0
Noncontrolling interests	312.0	306.0
Total shareholders’ equity	69,701.0	64,170.0
Total liabilities and shareholders’ equity	$ 230,715.0	$ 222,449.0